Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −58,395−100.0% | Sold out | Holders |
| Q1 2026 | 58,395 | $1.09M | <0.1% | +226+0.4% | Added | Holders |
| Q4 2025 | 58,169 | $766.7K | <0.1% | +27,413+89.1% | Added | Holders |
| Q3 2025 | 30,756 | $220.5K | <0.1% | −3,534−10.3% | Reduced | Holders |
| Q2 2025 | 34,290 | $1.62M | <0.1% | −12,811−27.2% | Reduced | Holders |
| Q1 2025 | 47,101 | $1.84M | <0.1% | −3,894−7.6% | Reduced | Holders |
| Q4 2024 | 50,995 | $2.76M | <0.1% | +7,167+16.4% | Added | Holders |
| Q3 2024 | 43,828 | $2.21M | <0.1% | −5,214−10.6% | Reduced | Holders |
| Q2 2024 | 49,042 | $2.16M | <0.1% | +6,769+16.0% | Added | Holders |
| Q1 2024 | 42,273 | $2.12M | <0.1% | +3,376+8.7% | Added | Holders |
| Q4 2023 | 38,897 | $2.35M | <0.1% | +38,897 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −20,144−100.0% | Sold out | Holders |
| Q3 2022 | 20,144 | $160.0K | <0.1% | −11,116−35.6% | Reduced | Holders |
| Q2 2022 | 31,260 | $164.0K | <0.1% | +31,260 | New | Holders |